Targeting NADPH oxidases for the treatment of cancer and inflammation

Cellular and Molecular Life Sciences

Volumn 69, Issue 14, 2012, Pages 2435-2442

  Bonner, Michael Y ^a,b   Arbiser, Jack L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Fulvenes; Hemangioma; Lymphoma; Melanoma; NADPH oxidase; Triphenylmethanes; Wilms tumor 1

Indexed keywords

EOSIN; FULVENE 5; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOREDUCTASE INHIBITOR; PROPANOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; TRIPHENYLMETHANE; UNCLASSIFIED DRUG;

ALGORITHM; CANCER INVASION; CLINICAL EFFECTIVENESS; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME REGULATION; HEMANGIOMA; HUMAN; HYPOGLYCEMIA; INFLAMMATORY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR RECOGNITION; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT PLANNING; UPREGULATION;

ALGORITHMS; HUMANS; INFLAMMATION; NADPH OXIDASE; NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84864344675     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1017-2     Document Type: Review

References (58)

1. Al DR, Powell J, McCuaig C, Kokta V (2010) Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 63:1052-1057
2. Arbiser JL, Govindarajan B, Bai X, Onda H, Kazlauskas A, Lim SD, Amin MB, Claesson-Welsh L (2002) Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis. Am J Pathol 161:781-786 (Pubitemid 34988364)
3. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR, Folkman J (1997) Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA 94:861-866 (Pubitemid 27074412)
4. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99:715-720 (Pubitemid 34106576)
5. Balasubramanian A, Ganju RK, Groopman JE (2003) Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem 278:35755-35766 (Pubitemid 37102352)
6. Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245-313 (Pubitemid 46209993)
7. Bhandarkar SS, Jaconi M, Fried LE, Bonner MY, Lefkove B, Govindarajan B, Perry BN, Parhar R, Mackelfresh J, Sohn A, Stouffs M, Knaus U, Yancopoulos G, Reiss Y, Benest AV, Augustin HG, Arbiser JL (2009) Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice. J Clin Invest 119:2359-2365
8. Block K, Gorin Y, Hoover P, Williams P, Chelmicki T, Clark RA, Yoneda T, Abboud HE (2007) NAD(P)H oxidases regulate HIF-2alpha protein expression. J Biol Chem 282:8019-8026 (Pubitemid 47093603)
9. Boivin B, Zhang S, Arbiser JL, Zhang ZY, Tonks NK (2008) A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells. Proc Natl Acad Sci USA 105:9959-9964
10. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, Whorton AR, Hoidal JR (2002) An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 282:C1212-C1224 (Pubitemid 34663069)
11. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 105:9035-9040
12. Cerimele F, Battle T, Lynch R, Frank DA, Murad E, Cohen C, Macaron N, Sixbey J, Smith K, Watnick RS, Eliopoulos A, Shehata B, Arbiser JL (2005) Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci USA 102:175-179 (Pubitemid 40094448)
13. Cerimele F, Brown LF, Bravo F, Ihler GM, Kouadio P, Arbiser JL (2003) Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoietin-2 and epidermal production of vascular endothelial growth factor. Am J Pathol 163:1321-1327 (Pubitemid 37175081)
14. Cohen C, Zavala-Pompa A, Sequeira JH, Shoji M, Sexton DG, Cotsonis G, Cerimele F, Govindarajan B, Macaron N, Arbiser JL (2002) Mitogen-activated protein kinase activation is an early event in melanoma progression. Clin Cancer Res 8:3728-3733 (Pubitemid 35424762)
15. Cowley S, Paterson H, Kemp P, Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852 (Pubitemid 24187682)
16. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, Pinkel D, Bastian BC (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-2147 (Pubitemid 41653105)
17. Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, Prieto VG, Aldape K, Mills GB, Gershenwald JE (2009) Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clin Cancer Res 15:7538-7546
18. De SC, De SP, Di MG, Venier A, Cerimele D, Serri F (1989) Reactive oxygen species production in circulating polymorphonuclear leukocytes in psoriasis. Acta Derm Venereol Suppl (Stockh) 146:50-52 (Pubitemid 20013741)
19. Dudnakova T, Spraggon L, Slight J, Hastie N (2010) Actin: a novel interaction partner of WT1 influencing its cell dynamic properties. Oncogene 29:1085-1092
20. Fried L, Arbiser JL (2008) The reactive oxygen-driven tumor: relevance to melanoma. Pigment Cell Melanoma Res 21:117-122 (Pubitemid 351559580)
21. Garrido-Urbani S, Jemelin S, Deffert C, Carnesecchi S, Basset O, Szyndralewiez C, Heitz F, Page P, Montet X, Michalik L, Arbiser J, Ruegg C, Krause KH, Imhof B (2011) Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARalpha mediated mechanism. PLoS ONE 6:e14665
22. Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL (2008) HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14:435-446
23. Govindarajan B, Bai X, Cohen C, Zhong H, Kilroy S, Louis G, Moses M, Arbiser JL (2003) Malignant transformation of melanocytes to melanoma by constitutive activation of mitogenactivated protein kinase kinase (MAPKK) signaling. J Biol Chem 278:9790-9795 (Pubitemid 36800479)
24. Govindarajan B, Klafter R, Miller MS, Mansur C, Mizesko M, Bai X, LaMontagne K Jr, Arbiser JL (2002) Reactive oxygeninduced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med 8:1-8 (Pubitemid 34451115)
25. Govindarajan B, Shah A, Cohen C, Arnold RS, Schechner J, Chung J, Mercurio AM, Alani R, Ryu B, Fan CY, Cuezva JM, Martinez M, Arbiser JL (2005) Malignant transformation of human cells by constitutive expression of platelet-derived growth factor-BB. J Biol Chem 280:13936-13943 (Pubitemid 40517294)
26. Govindarajan B, Sligh JE, Vincent BJ, Li M, Canter JA, Nickoloff BJ, Rodenburg RJ, Smeitink JA, Oberley L, Zhang Y, Slingerland J, Arnold RS, Lambeth JD, Cohen C, Hilenski L, Griendling K, Martinez-Diez M, Cuezva JM, Arbiser JL (2007) Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J Clin Invest 117:719-729 (Pubitemid 46348530)
27. Hanselmann C, Mauch C, Werner S (2001) Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis? Biochem J 353:459-466 (Pubitemid 32158313)
28. Klangby U, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG (1998) p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 91:1680-1687 (Pubitemid 28110333)
29. Lambeth JD, Kawahara T, Diebold B (2007) Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 43:319-331 (Pubitemid 46978416)
30. LaMontagne KR Jr, Moses MA, Wiederschain D, Mahajan S, Holden J, Ghazizadeh H, Frank DA, Arbiser JL (2000) Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. Am J Pathol 157:1937-1945
31. Lapidoth M, Ben-Amitai D, Bhandarkar S, Fried L, Arbiser JL (2009) Efficacy of topical application of eosin for ulcerated hemangiomas. J Am Acad Dermatol 60:350-351
32. Lawley LP, Cerimele F, Weiss SW, North P, Cohen C, Kozakewich HP, Mulliken JB, Arbiser JL (2005) Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol 141:1297-1300 (Pubitemid 41498928)
33. Leaute-Labreze C, de la Dumas RE, Hubiche T, Boralevi F, Thambo JB, Taieb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649-2651 (Pubitemid 351831393)
34. Lee HM, Shin DM, Yuk JM, Shi G, Choi DK, Lee SH, Huang SM, Kim JM, Kim CD, Lee JH, Jo EK (2011) Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62/SQSTM1. J Immunol 186:1248-1258
35. Levine SM (1992) The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med Hypotheses 39:271-274
36. Lunec J, Herbert K, Blount S, Griffiths HR, Emery P (1994) 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 348:131-138
37. Maranchie JK, Zhan Y (2005) Nox4 is critical for hypoxiainducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res 65:9190-9193 (Pubitemid 41507983)
38. Mishra MV, Bisht KS, Sun L, Muldoon-Jacobs K, Awwad R, Kaushal A, Nguyen P, Huang L, Pennington JD, Markovina S, Bradbury CM, Gius D (2008) DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells. Mol Cancer Res 6:243-249 (Pubitemid 351342412)
39. Mochizuki T, Furuta S, Mitsushita J, Shang WH, Ito M, Yokoo Y, Yamaura M, Ishizone S, Nakayama J, Konagai A, Hirose K, Kiyosawa K, Kamata T (2006) Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 25:3699-3707 (Pubitemid 43980491)
40. Orcutt KP, Parsons AD, Sibenaller ZA, Scarbrough PM, Zhu Y, Sobhakumari A, Wilke WW, Kalen AL, Goswami P, Miller FJ Jr, Spitz DR, Simons AL (2011) Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4. Cancer Res 71:3932-3940
41. Perry BN, Govindarajan B, Bhandarkar SS, Knaus UG, Valo M, Sturk C, Carrillo CO, Sohn A, Cerimele F, Dumont D, Losken A, Williams J, Brown LF, Tan X, Ioffe E, Yancopoulos GD, Arbiser JL (2006) Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol 126:2316-2322 (Pubitemid 44413180)
42. Perry DK, Hand WL, Edmondson DE, Lambeth JD (1992) Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase. Inhibition by phosphatidic acid phosphohydrolase inhibitors. J Immunol 149:2749-2758
43. Qiu RG, Chen J, Kirn D, McCormick F, Symons M (1995) An essential role for Rac in Ras transformation. Nature 374:457-459
44. Sanz-Cameno P, Martin-Vilchez S, Lara-Pezzi E, Borque MJ, Salmeron J, de Munoz RP, Solis JA, Lopez-Cabrera M, Moreno-Otero R (2006) Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV X protein. Am J Pathol 169:1215-1222 (Pubitemid 351194358)
45. Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258 (Pubitemid 21905698)
46. Shinohara M, Shang WH, Kubodera M, Harada S, Mitsushita J, Kato M, Miyazaki H, Sumimoto H, Kamata T (2007) Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 282:17640-17648 (Pubitemid 47100324)
47. Stoff B, Mackelfresh J, Fried L, Cohen C, Arbiser JL (2010) A nonsteroidal alternative to impetiginized eczema in the emergency room. J Am Acad Dermatol 63:537-539
48. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794-798
49. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA (1994) Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93:2357-2364 (Pubitemid 24177146)
50. Torisu-Itakura H, Lee JH, Huynh Y, Ye X, Essner R, Morton DL (2007) Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients. J Immunother 30:831-838 (Pubitemid 350295362)
51. Trindade F, Tellechea O, Torrelo A, Requena L, Colmenero I (2011) Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol 33(6):569-572
52. Verma A, Ihler GM (2002) Activation of Rac, Cdc42 and other downstream signalling molecules by Bartonella bacilliformis during entry into human endothelial cells. Cell Microbiol 4:557-569
53. Vicent S, Chen R, Sayles LC, Lin C, Walker RG, Gillespie AK, Subramanian A, Hinkle G, Yang X, Saif S, Root DE, Huff V, Hahn WC, Sweet-Cordero EA (2010) Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest 120:3940-3952
54. Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-270
55. Weaver-Feldhaus J, Gruis NA, Neuhausen S, Le PD, Stockert E, Skolnick MH, Kamb A (1994) Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc Natl Acad Sci USA 91:7563-7567 (Pubitemid 24238225)
56. Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, Goto Y, Shang WH, Kubodera M, Kato M, Takata M, Saida T, Kamata T (2009) NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res 69:2647-2654
57. Yamini B, Yu X, Dolan ME, Wu MH, Kufe DW, Weichselbaum RR (2007) Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. Cancer Res 67:6889-6898 (Pubitemid 47105536)
58. Zietz C, Rossle M, Haas C, Sendelhofert A, Hirschmann A, Sturzl M, Lohrs U (1998) MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol 153:1425-1433 (Pubitemid 28509898)